Stowers Institute For Medical Research

Stowers Institute For Medical Research, a tax-exempt nonprofit research organization headquartered in Kansas City, Missouri, is a federal grant recipient conducting fundamental biomedical research funded primarily by National Institutes of Health (NIH) grants. The institute operates as a prime recipient on federal project grants (91% of recent awards) and participates as a sub-recipient on collaborative research efforts, with no federal contract footprint and no participation in government-wide contract vehicles.

The institute's federal funding concentrates heavily within NIH. The top five funding agencies account for 71% of recent awards, with the National Institutes of Health serving as the overarching customer across 20 total awards. Within NIH, the National Institute of General Medical Sciences funds the largest volume (16 awards), followed by the National Institute of Child Health and Human Development (11 awards), the National Institute of Dental and Craniofacial Research (7 awards), and the National Institute on Aging. The combined dollars obligated across all federal sources total $103.8 million.

Stowers Institute's research portfolio spans developmental biology, aging, and reproductive health. Representative prime grant work includes a $429 thousand, five-year Project Grant from NIGMS (Biomedical Research and Research Training program, CFDA 93.859) awarded February 2026 investigating maternal messenger RNA function during zebrafish embryogenesis and the maternal-to-zygotic transition; a $371,250, five-year Project Grant from NIDCR (Oral Diseases and Disorders Research program, CFDA 93.121) awarded March 2026 on craniofacial anomaly pathogenesis and prevention; and a $125,619, five-year Project Grant from the National Cancer Institute (Cancer Cause and Prevention Research program, CFDA 93.393) awarded August 2025 examining centromere biology and chromosome segregation mechanisms underlying genomic instability. Additional active work addresses protein aggregation and aging, neural crest cell development and craniofacial disorders, ribosome biogenesis, and meiotic drive mechanisms using model organisms including zebrafish and Drosophila.

The institute participates as a sub-recipient on collaborative grants anchored at partner institutions including New York University (enhancer-Gal4 line development), Children's Mercy Hospital (organoid models and genome-scale CRISPR screening for birth defects), University of California Riverside (non-coding RNA regulation), Arizona State University (cortical microtubule patterning), University of Missouri System (fish metabolism and sleep phenotypes), and Northwestern University (oocyte aging and spatial transcriptomics). The sub-award portfolio accounts for 9% of the recent award footprint and reflects the institute's role as a specialized research laboratory contributing molecular and cellular analysis methods to multi-institutional projects.

Activity has been intermittent over the past five years — six awards in 2022, three in 2023, five in 2024, four in 2025, and five in 2026 — reflecting the cycle of NIH grant competition rather than consistent growth. Seven awards face ultimate completion within the next twenty-four months, representing potential recompete opportunity. The institute has not historically competed for federal contracts; its federal footprint is grant-based and driven by principal investigator-led research proposals to NIH institutes and centers.